Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US
Jing Sun, Qulu Zheng, Vithal Madhira, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 153-153
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge
Christopher Radcliffe, Carlo Foppiano Palacios, Marwan M. Azar, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 10, pp. 2458-2463
Open Access | Times Cited: 80
Association Between AZD7442 (Tixagevimab-Cilgavimab) Administration and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Hospitalization, and Mortality
Jennifer Kertes, Shirley Shapiro Ben David, Noya Engel-Zohar, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e126-e132
Open Access | Times Cited: 68
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
Felicia Ceban, Dana Kulzhabayeva, Nelson B. Rodrigues, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 211-229
Open Access | Times Cited: 63
COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada
Taraneh Bahremand, Jiayun Yao, Christopher Mill, et al.
The Lancet Regional Health - Americas (2023) Vol. 20, pp. 100461-100461
Open Access | Times Cited: 41
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States
Sally B. Coburn, Elizabeth Humes, Raynell Lang, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2215934-e2215934
Open Access | Times Cited: 65
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 60
Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir
Emily S. Ford, William Simmons, Ellora Karmarkar, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 5, pp. 926-929
Open Access | Times Cited: 57
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
Laura Boekel, Eileen W Stalman, Luuk Wieske, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e417-e429
Open Access | Times Cited: 50
Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals
Austin D Vo, Jennifer La, Julie T.-Y. Wu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2240037-e2240037
Open Access | Times Cited: 45
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice
Essy Mozaffari, Aastha Chandak, Robert Gottlieb, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 12, pp. 1626-1634
Open Access | Times Cited: 33
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 29
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
Matteo Augello, Valeria Bono, Roberta Rovito, et al.
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 2, pp. 51-75
Open Access | Times Cited: 25
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
Delphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 5, pp. 649-658
Open Access | Times Cited: 24
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
Simon Feys, Katrien Lagrou, Hanne Moon Lauwers, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 361-370
Open Access | Times Cited: 23
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection
Zeno Pasquini, Alice Toschi, Beatrice Casadei, et al.
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 904-911
Open Access | Times Cited: 22
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
Naomi J. Patel, Xiaosong Wang, Xiaoqing Fu, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 58, pp. 152108-152108
Open Access | Times Cited: 36
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile
María Elvira Balcells, Nicole Le Corre, Josefina Durán, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e594-e602
Open Access | Times Cited: 33
Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark
Sebastian Rask Hamm, Omid Rezahosseini, Dina Leth Møller, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 11, pp. 2637-2650
Open Access | Times Cited: 33
Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US
Raynell Lang, Elizabeth Humes, Sally B. Coburn, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236397-e2236397
Open Access | Times Cited: 33
The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls
Amanda J. Vinson, Alfred Anzalone, Jing Sun, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 10, pp. 2418-2432
Open Access | Times Cited: 31
Breakthrough SARS – CoV ‐2 Infections in Patients With Immune‐Mediated Disease Undergoing B Cell–Depleting Therapy: A Retrospective Cohort Analysis
Cassandra Calabrese, E. Kirchner, M. Elaine Husni, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 12, pp. 1906-1915
Open Access | Times Cited: 31
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY
Fiona Pearce, Sean H. Lim, Mary Bythell, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 8, pp. e461-e473
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top